93 related articles for article (PubMed ID: 23156299)
41. Recurrent ovarian malignancy: patterns and spectrum of imaging findings.
Park CM; Kim SH; Kim SH; Moon MH; Kim KW; Choi HJ
Abdom Imaging; 2003; 28(3):404-15. PubMed ID: 12719914
[TBL] [Abstract][Full Text] [Related]
42. Predictors of timing and patterns of recurrence after curative resection for gastric cancer.
Eom BW; Yoon H; Ryu KW; Lee JH; Cho SJ; Lee JY; Kim CG; Choi IJ; Lee JS; Kook MC; Park SR; Nam BH; Kim YW
Dig Surg; 2010; 27(6):481-6. PubMed ID: 21063125
[TBL] [Abstract][Full Text] [Related]
43. [Analysis of ovarian metastasis of colorectal cancer--a comparison between ovarian metastasis and peritoneal metastasis without involving ovaries].
Ishii M; Ishibashi K; Ishiguro T; Kuwabara K; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2257-9. PubMed ID: 20037388
[TBL] [Abstract][Full Text] [Related]
44. [Gliomatosis peritonei. An unusual form of metastasis of an immature ovarian teratoma].
Mitze M; Wagner R
Pathologe; 1986 Jul; 7(4):222-4. PubMed ID: 3737567
[No Abstract] [Full Text] [Related]
45. Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer.
Sakai K; Kamura T; Hirakawa T; Saito T; Kaku T; Nakano H
Gynecol Oncol; 1997 Apr; 65(1):164-8. PubMed ID: 9103407
[TBL] [Abstract][Full Text] [Related]
46. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.
Fagotti A; Vizzielli G; Fanfani F; Scambia G
Am J Obstet Gynecol; 2010 Sep; 203(3):e10-1; author reply e11. PubMed ID: 20594544
[No Abstract] [Full Text] [Related]
47. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.
Fujioka T; Takebayashi Y; Kihana T; Kusanagi Y; Hamada K; Ochi H; Uchida T; Fukumoto M; Ito M
Oncol Rep; 2001; 8(2):249-55. PubMed ID: 11182035
[TBL] [Abstract][Full Text] [Related]
48. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
Ruan HY; Li DR; Li L; Guan X; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
[TBL] [Abstract][Full Text] [Related]
49. Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer.
Yin M; Li C; Li X; Lou G; Miao B; Liu X; Meng F; Zhang H; Chen X; Sun M; Ling Q; Zhou R
J Surg Oncol; 2011 Jul; 104(1):29-36. PubMed ID: 21416470
[TBL] [Abstract][Full Text] [Related]
50. Antigenic structure of ovarian cancer metastases.
Prokopenko PG; Borisenko SA; Terent'ev AA
Bull Exp Biol Med; 2001 Jun; 131(6):561-3. PubMed ID: 11586407
[TBL] [Abstract][Full Text] [Related]
51. [Mechanism of metastasis in endometrial cancer].
Saito T; Tanaka R; Iwasaki M
Nihon Rinsho; 2012 Jun; 70 Suppl 4():317-20. PubMed ID: 23156263
[No Abstract] [Full Text] [Related]
52. Initialization of epithelial cells by tumor cells in a metastatic microenvironment.
Hayashi T; Sano K; Aburatani H; Yaegashi N; Konishi I
Oncogene; 2020 Mar; 39(12):2638-2640. PubMed ID: 32015485
[No Abstract] [Full Text] [Related]
53. Aggressive ovarian cancer may be linked to blood disorder.
Oncology (Williston Park); 2002 Jul; 16(7):901. PubMed ID: 12164556
[No Abstract] [Full Text] [Related]
54. Circulating tumor cells revisited.
Cristofanilli M; Braun S
JAMA; 2010 Mar; 303(11):1092-3. PubMed ID: 20233831
[No Abstract] [Full Text] [Related]
55. Comprehensive overview about ovarian cancer and secondary peritoneal tumors.
Cianci S; Scambia G
Minerva Med; 2019 Aug; 110(4):277-278. PubMed ID: 31142098
[No Abstract] [Full Text] [Related]
56. A surgeon's view of the spread of breast cancer.
Handley RS
Cancer; 1969 Dec; 24(6):1231-4. PubMed ID: 5353969
[No Abstract] [Full Text] [Related]
57. Ovarian cancer presenting with inguinal metastasis 33 months prior to intraabdominal disease.
Shetty MR
Gynecol Oncol; 1994 Mar; 52(3):420. PubMed ID: 8157203
[No Abstract] [Full Text] [Related]
58. Circulating cancer cells.
Lancet; 1967 Jul; 2(7506):84-5. PubMed ID: 4165472
[No Abstract] [Full Text] [Related]
59. Circulating tumor cells: is this gold or pyrite?
Gehrig PA
Obstet Gynecol; 2011 May; 117(5):1037-1039. PubMed ID: 21508740
[No Abstract] [Full Text] [Related]
60. The price of anticancer intervention. Does surgery promote metastasis?
Ben-Eliyahu S
Lancet Oncol; 2002 Sep; 3(9):578-9. PubMed ID: 12233735
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
